Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

Best and worst states for physicians to practice in 2019

With high compensation and a good work-life balance, Minnesota is the best state for physicians to thrive in 2019, according to a recent ranking from Medscape.

Thumbnail

Judge reviewing CVS-Aetna $69B merger unlikely to unravel deal

CVS Health is still embroiled in a dispute over its $69 billion merger with Aetna, which was approved by the Department of Justice last year and closed in late 2018. However, U.S. District Judge Richard Leon isn’t so sure the deal hasn’t crossed any antitrust laws and is reviewing the case in court.

FDA clears novel AI chest x-ray technology for pneumothorax

According to Zebra Medical Vision, their technology can save physicians more than 80% of the time it takes to reach the acute condition compared to the commonly used first in first out (FIFO) method.

Thumbnail

Hospitals charged private insurers more than Medicare

Private health insurance plans, which cover the majority of people in the U.S., paid higher rates to hospitals compared to public plans such as Medicare and Medicaid, according to a recent report from RAND.

 

Thumbnail

Trump administration wants to end surprise billing

President Trump announced principles to address the issue of surprise billing in healthcare, the White House announced May 9.

Thumbnail

Savings in Medicare Advantage related to lower spending before beneficiaries enroll

The savings that Medicare Advantage plans can bring to the table may have been over-weighted after a recent study revealed seniors who switch from traditional Medicare plans already have lower healthcare costs before they join an MA plan.

Thumbnail

FDA to end alternative summary reporting

The FDA is putting an end to a program that allowed medical device companies to keep the public in the dark about reports of harm and malfunction. The program, called alternative summary reporting, was established in 1997 and its data has not been publicly available.

Thumbnail

Basing US drug prices on an international reference could save billions

Adopting the prices of other countries could potentially have helped save Medicare part D as much as $72.8 billion in 2018, as drug prices in the U.S. averaged 3.2 to 4.1 times higher after rebates compared to the U.K., Japan and Ontario, Canada, according to a study published in Health Affairs.